Eighty-two percent of public firms have golden parachutes (or “chutes”) under which CEOs and senior officers may be paid tens of millions of dollars upon their employer's change in control. What justifies such extraordinary payouts?Much of the conventional analysis views chutes as excessive...

Innovation is crucial to economic growth – the essential path for lifting much of the world population out of dire poverty and for maintaining the living standard of those who already have. To stimulate innovation, the legal system has to support the means through which innovators seek to get...

The Australian patent system provides protection for both standard and innovation patents. The case of Dura-Post (Aust) Pty Ltd v Delnorth Pty Ltd concerns three innovation patents owned by Delnorth for an invention for a ‘‘Roadside Post’’ for supporting signage or delineating paths,...

The patent systems in Europe, the United States and many other countries exempt medical treatment methods from patentability or shield physicians from the enforcement of such patents. While various policy reasons for such exceptions can be traced back decades and even centuries, today the...

Intellectual property is a potent and increasingly vital driver of value in America's Digital Age economy. Indeed, along with the Internet, intellectual property is one of the pillars upon which the Digital Age economy rests.According to the U.S. Commerce Department's comprehensive report,...

Unmanned aerial vehicles — “UAVs” or “drones” — are increasingly becoming a mainstream commercial phenomenon and tool for a vast range of commercial consumer, prosumer, and professional activities. Given advances in automation and miniaturization generally — and flight control...

In 2022, the White House released a regulatory framework calling for a whole-of-government approach to digital asset innovations. Although justified and necessary, this systems-based strategy discounts the reality that U.S. financial regulation is fundamentally fragmented. There are signs of a...

This paper looks at whether the standard unilateral effects model can be applied to non-price competition parameters such as innovation. This question arises because competition authorities are intervening in horizontal mergers that are found to give rise to a “significant impediment to...

The National Institutes of Health (NIH) are responsible for the largest proportion of biological science funding in the United States. To protect the public interest in access to publicly funded scientific research, the NIH amended terms and conditions in funding agreements after 2009, requiring...

A number of antitrust cases have challenged firm conduct associated with the introduction of a new product. Several are in the pharmaceutical industry and have earned the moniker of “product hopping.” Other cases involve the design of interfaces that defeat interoperability and the supply of...